Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

The iOS 26.4 update that Apple is beta testing includes a new "Playlist Playground" feature in the Apple Music app that's designed to let users create a playlist with a text-based prompt. In the ...

Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. During that time he has reviewed hundreds of ...

Macworld reports that iOS 26.4 beta introduces “Playlist Playground,” an AI-powered feature allowing Apple Music subscribers to create custom playlists using text prompts or song selections. The ...

Apple released the first beta of iOS 26.4 for developers today, and it includes a new Apple Intelligence feature for Apple Music. Dubbed “Playlist Playground,” this feature lets you create playlists ...

Pranay Parab is an independent tech journalist based in Mumbai, India. He covers tech for Lifehacker, and specializes in tutorials and in-depth features. Apple Music is testing a new AI playlist ...

Music streaming is supposed to be easy. Tap a button, press the play button, and your choice of music starts playing anywhere and everywhere you want. Be it at your work desk, while driving, or when ...